| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 717024 | 82294 | DAPTOMICINA AVALON 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | DAPTOMICINA AVALON 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial | 350 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82294/82294_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82294/82294_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34734 | AVALON LABORATORIOS S.L. | 2017-11-22 | 1 | 1 | 1 | 2017-11-22 | 2017-11-22 | 1 | 2018-11-21 | View Edit Delete | ||||||||||||
| 717026 | 82295 | DAPTOMICINA AVALON 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | DAPTOMICINA AVALON 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial | 500 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82295/82295_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82295/82295_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34734 | AVALON LABORATORIOS S.L. | 2017-11-22 | 1 | 1 | 1 | 2017-11-22 | 2017-11-22 | 1 | 2018-11-21 | View Edit Delete | ||||||||||||
| 730313 | 85751 | DAPTOMICINA CIPLA 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | DAPTOMICINA CIPLA 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial | 350 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85751/85751_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85751/85751_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68210 | CIPLA EUROPE NV SUCURSAL EN ESPANA | 2021-02-03 | 1 | 1 | 1 | 2021-02-04 | 2021-02-03 | 1 | 2021-07-05 | View Edit Delete | ||||||||||||
| 730314 | 85752 | DAPTOMICINA CIPLA 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | DAPTOMICINA CIPLA 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial | 500 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85752/85752_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85752/85752_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68210 | CIPLA EUROPE NV SUCURSAL EN ESPANA | 2021-02-03 | 1 | 1 | 1 | 2021-02-04 | 2021-02-03 | 1 | 2021-07-05 | View Edit Delete | ||||||||||||
| 719232 | 82483 | DAPTOMICINA DR. REDDYS 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | DAPTOMICINA DR. REDDYS 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial | 350 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82483/82483_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82483/82483_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27152 | REDDY PHARMA IBERIA S.A. | 2018-01-11 | 1 | 1 | 1 | 2018-01-11 | 2018-01-11 | 1 | 2019-07-26 | View Edit Delete | ||||||||||||
| 719233 | 82484 | DAPTOMICINA DR. REDDYS 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | DAPTOMICINA DR. REDDYS 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial | 500 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82484/82484_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82484/82484_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27152 | REDDY PHARMA IBERIA S.A. | 2018-01-11 | 1 | 1 | 1 | 2018-01-11 | 2018-01-11 | 1 | 2019-07-25 | View Edit Delete | ||||||||||||
| 764653 | 89474 | DAPTOMICINA HIKMA 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | DAPTOMICINA HIKMA 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial de 20 ml | 350 mg | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89474/89474_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89474/89474_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14340 | HIKMA ESPAÑA, S.L.U. | 2024-06-04 | 1 | 1 | 1 | 2024-06-04 | 2024-06-04 | 1 | 2025-10-21 | View Edit Delete | ||||||||||||
| 764656 | 89475 | DAPTOMICINA HIKMA 500 MG POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN EFG | DAPTOMICINA HIKMA 500 MG POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN EFG, 1 vial | 500 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89475/89475_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89475/89475_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14340 | HIKMA ESPAÑA, S.L.U. | 2024-06-04 | 1 | 1 | 1 | 2024-06-04 | 2024-06-04 | 1 | 2025-10-21 | View Edit Delete | ||||||||||||
| 726160 | 84268 | DAPTOMICINA NORMON 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | DAPTOMICINA NORMON 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial | 350 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84268/84268_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84268/84268_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2019-06-18 | 1 | 1 | 1 | 2019-06-19 | 2019-06-18 | 1 | 2021-01-20 | View Edit Delete | ||||||||||||
| 726192 | 84285 | DAPTOMICINA NORMON 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | DAPTOMICINA NORMON 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial | 500 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84285/84285_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84285/84285_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2019-06-28 | 1 | 1 | 1 | 2019-06-29 | 2019-06-28 | 1 | 2021-01-20 | View Edit Delete | ||||||||||||
| 721477 | 83056 | DAPTOMICINA SALA 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | DAPTOMICINA SALA 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial | 350 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83056/83056_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83056/83056_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2018-07-12 | 1 | 1 | 1 | 2018-07-12 | 2018-07-12 | 1 | 2020-09-20 | View Edit Delete | ||||||||||||
| 721479 | 83057 | DAPTOMICINA SALA 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | DAPTOMICINA SALA 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial | 500 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83057/83057_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83057/83057_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2018-07-13 | 1 | 1 | 1 | 2018-07-13 | 2018-07-13 | 1 | 2020-09-20 | View Edit Delete | ||||||||||||
| 763253 | 89001 | DAPTOMICINA TARBIS 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | DAPTOMICINA TARBIS 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial | 350 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89001/89001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89001/89001_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2023-08-06 | 1 | 1 | 1 | 2023-08-07 | 2023-08-06 | 1 | 2023-10-17 | View Edit Delete | ||||||||||||
| 763254 | 89002 | DAPTOMICINA TARBIS 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | DAPTOMICINA TARBIS 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial | 500 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89002/89002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89002/89002_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2023-08-06 | 1 | 1 | 1 | 2023-08-07 | 2023-08-06 | 1 | 2023-10-17 | View Edit Delete | ||||||||||||
| 719970 | 82669 | DAPTOMICINA XELLIA 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | DAPTOMICINA XELLIA 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial | 350 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82669/82669_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82669/82669_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11187 | SUN PHARMA LABORATORIOS S.L. | 2018-12-28 | 1 | 1 | 1 | 2018-12-28 | 2018-12-28 | 1 | 2020-09-14 | View Edit Delete | ||||||||||||
| 719972 | 82670 | DAPTOMICINA XELLIA 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | DAPTOMICINA XELLIA 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial | 500 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82670/82670_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82670/82670_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11187 | SUN PHARMA LABORATORIOS S.L. | 2018-12-26 | 1 | 1 | 1 | 2018-12-26 | 2018-12-26 | 1 | 2020-05-15 | View Edit Delete | ||||||||||||
| 653411 | 19625 | DARAPRIM 25 mg COMPRIMIDOS | DARAPRIM 25 mg COMPRIMIDOS, 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/19625/19625_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/19625/19625_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4817 | SMITHKLINE BEECHAM FARMA S.A. | 1953-07-01 | 1 | 1 | 1 | 1953-07-01 | 2011-11-29 | 1 | 2012-01-02 | 739961 | View Edit Delete | |||||||||||
| 763597 | 89089 | DARIANTE 1 MG/24 HORAS PARCHES TRANSDÉRMICOS EFG | DARIANTE 1 MG/24 HORAS PARCHES TRANSDÉRMICOS EFG, 28 parches | 1 mg/24 h | 35 | 28 | 28 | 28 parches | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89089/89089_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89089/89089_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | EXELTIS HEALTHCARE S.L. | 2023-10-17 | 1 | 1 | 1 | 2023-10-18 | 2023-10-17 | 0 | 2025-04-11 | View Edit Delete | ||||||||||||
| 763598 | 89090 | DARIANTE 2 MG/24 HORAS PARCHES TRANSDÉRMICOS EFG | DARIANTE 2 MG/24 HORAS PARCHES TRANSDÉRMICOS EFG, 28 parches | 2 mg/24 h | 35 | 28 | 28 | 28 parches | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89090/89090_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89090/89090_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | EXELTIS HEALTHCARE S.L. | 2023-10-17 | 1 | 1 | 1 | 2023-10-18 | 2023-10-17 | 0 | 2025-04-11 | View Edit Delete | ||||||||||||
| 763599 | 89091 | DARIANTE 3 MG/24 HORAS PARCHES TRANSDÉRMICOS EFG | DARIANTE 3 MG/24 HORAS PARCHES TRANSDÉRMICOS EFG, 28 parches | 3 mg/24 h | 35 | 28 | 28 | 28 parches | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89091/89091_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89091/89091_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | EXELTIS HEALTHCARE S.L. | 2023-10-17 | 1 | 1 | 1 | 2023-10-18 | 2023-10-17 | 0 | 2025-04-11 | View Edit Delete |
Page 244 of 1035, showing 20 records out of 20697 total, starting on record 4861, ending on 4880